Format
Sort by
Items per page

Send to

Choose Destination

Best matches for "breast cancer":

Awareness and current knowledge of breast cancer. Akram M et al. Biol Res. (2017)

Breast cancer metastasis. Scully OJ et al. Cancer Genomics Proteomics. (2012)

Risk Factors and Preventions of Breast Cancer. Sun YS et al. Int J Biol Sci. (2017)

Search results

Items: 1 to 20 of 248732

1.

How do breast cancer patients experience multidisciplinary tumor conferences? - A description from the patient perspective.

Diekmann A, Heuser C, Ernstmann N, Geiser F, Groß SE, Midding E, Pfaff H, Ansmann L.

Breast. 2019 Jan 4;44:66-72. doi: 10.1016/j.breast.2018.12.012. [Epub ahead of print]

PMID:
30669033
2.

The changes of quality of life and their correlations with psychosocial factors following surgery among women with breast cancer from the post-surgery to post-treatment survivorship.

Hsiao FH, Kuo WH, Jow GM, Wang MY, Chang KJ, Lai YM, Chen YT, Huang CS.

Breast. 2019 Jan 4;44:59-65. doi: 10.1016/j.breast.2018.12.011. [Epub ahead of print]

PMID:
30669032
3.

Smoking and breast cancer risk by race/ethnicity and oestrogen and progesterone receptor status: the Multiethnic Cohort (MEC) study.

Gram IT, Park SY, Maskarinec G, Wilkens LR, Haiman CA, Le Marchand L.

Int J Epidemiol. 2019 Jan 18. doi: 10.1093/ije/dyy290. [Epub ahead of print]

PMID:
30668861
4.

Stem cell-like breast cancer cells with acquired resistance to metformin are sensitive to inhibitors of NADH-dependent CtBP dimerization.

Banerjee A, Birts CN, Darley M, Parker R, Mirnezami AH, West J, Cutress RI, Beers SA, Rose-Zerilli MJ, Blaydes JP.

Carcinogenesis. 2019 Jan 22. doi: 10.1093/carcin/bgy174. [Epub ahead of print]

PMID:
30668646
5.

The FDA-Approved Breast Cancer HER2 Evaluation Kit (HercepTest; Dako) May Miss Some HER2-Positive Breast Cancers.

Schneider F, Jin Y, Van Smaalen K, Gulbahce EH, Factor RE, Li X.

Am J Clin Pathol. 2019 Jan 21. doi: 10.1093/ajcp/aqy171. [Epub ahead of print]

PMID:
30668632
6.

Antioxidant supplementation and breast cancer prognosis in postmenopausal women undergoing chemotherapy and radiation therapy.

Jung AY, Cai X, Thoene K, Obi N, Jaskulski S, Behrens S, Flesch-Janys D, Chang-Claude J.

Am J Clin Nutr. 2019 Jan 21. doi: 10.1093/ajcn/nqy223. [Epub ahead of print]

PMID:
30668630
7.

Inhibiting neddylation modification alters mitochondrial morphology and reprograms energy metabolism in cancer cells.

Zhou Q, Li H, Li Y, Tan M, Fan S, Cao C, Meng F, Zhu L, Zhao L, Guan MX, Jin H, Sun Y.

JCI Insight. 2019 Jan 22. pii: 121582. doi: 10.1172/jci.insight.121582. [Epub ahead of print]

PMID:
30668548
8.

An Electronic Patient-Reported Outcome Tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) Questionnaire for Measuring the Health-Related Quality of Life in Patients With Breast Cancer: Reliability Study.

Matthies LM, Taran FA, Keilmann L, Schneeweiss A, Simoes E, Hartkopf AD, Sokolov AN, Walter CB, Sickenberger N, Wallwiener S, Feisst M, Gass P, Lux MP, Schuetz F, Fasching PA, Sohn C, Brucker SY, Graf J, Wallwiener M.

J Med Internet Res. 2019 Jan 22;21(1):e10004. doi: 10.2196/10004.

PMID:
30668517
9.

Different effects of 4β-hydroxywithanolide E and withaferin A, two withanolides from Solanaceae plants, on the Akt signaling pathway in human breast cancer cells.

Wang HC, Hu HH, Chang FR, Tsai JY, Kuo CY, Wu YC, Wu CC.

Phytomedicine. 2018 Sep 5;53:213-222. doi: 10.1016/j.phymed.2018.09.017. [Epub ahead of print]

PMID:
30668401
10.

Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33/2).

von Hagens C, Walter-Sack I, Goeckenjan M, Storch-Hagenlocher B, Sertel S, Elsässer M, Remppis BA, Munzinger J, Edler L, Efferth T, Schneeweiss A, Strowitzki T.

Phytomedicine. 2018 Sep 17;54:140-148. doi: 10.1016/j.phymed.2018.09.178. [Epub ahead of print]

PMID:
30668363
11.

Adaptogens in chemobrain (Part III): Antitoxic effects of plant extracts towards cancer chemotherapy-induced toxicity - transcriptome-wide microarray analysis of neuroglia cells.

Seo EJ, Klauck SM, Efferth T, Panossian A.

Phytomedicine. 2018 Nov 9;56:246-260. doi: 10.1016/j.phymed.2018.11.011. [Epub ahead of print]

PMID:
30668345
12.

Evaluation of the safety profiles of estrogenic Chinese herbal medicines in breast cancer.

Yue GG, Wong LS, Leung HW, Gao S, Tsang JY, Lin ZX, Tse GM, Lau CB.

Phytomedicine. 2018 Oct 8;56:103-117. doi: 10.1016/j.phymed.2018.10.003. [Epub ahead of print]

PMID:
30668331
13.

Cell permeable NBD peptide-modified liposomes by hyaluronic acid coating for the synergistic targeted therapy of metastatic inflammatory breast cancer.

Sun Y, Li X, Zhang L, Liu X, Jiang B, Long Z, Jiang Y.

Mol Pharm. 2019 Jan 22. doi: 10.1021/acs.molpharmaceut.8b01123. [Epub ahead of print]

PMID:
30668131
14.

Presentation and Delivery of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand via Elongated Plant Viral Nanoparticle Enhances Antitumor Efficacy.

Le DHT, Commandeur U, Steinmetz NF.

ACS Nano. 2019 Jan 22. doi: 10.1021/acsnano.8b09462. [Epub ahead of print]

PMID:
30668110
15.

Breast Cancer Treatment: A Review.

Waks AG, Winer EP.

JAMA. 2019 Jan 22;321(3):288-300. doi: 10.1001/jama.2018.19323.

PMID:
30667505
16.

Breast Cancer Treatment.

Waks AG, Winer EP.

JAMA. 2019 Jan 22;321(3):316. doi: 10.1001/jama.2018.20751. No abstract available.

PMID:
30667503
17.

Sample size calculations for the differential expression analysis of RNA-seq data using a negative binomial regression model.

Li X, Wu D, Cooper NGF, Rai SN.

Stat Appl Genet Mol Biol. 2019 Jan 22. pii: /j/sagmb.ahead-of-print/sagmb-2018-0021/sagmb-2018-0021.xml. doi: 10.1515/sagmb-2018-0021. [Epub ahead of print]

PMID:
30667368
18.

The CDC42 effector protein MRCKβ autophosphorylates on Threonine 1108.

Unbekandt M, Lilla S, Zanivan S, Olson MF.

Small GTPases. 2019 Jan 22:1-10. doi: 10.1080/21541248.2018.1564472. [Epub ahead of print]

PMID:
30667325
19.

A Versatile and Ultrasensitive Electrochemiluminescence Biosensor for Biomarker Detection Based on Non-enzymatic Amplification and Aptamer-Triggered Emitter Release.

Nie Y, Yuan X, Zhang P, Chai Y, Yuan R.

Anal Chem. 2019 Jan 22. doi: 10.1021/acs.analchem.8b05001. [Epub ahead of print]

PMID:
30667212
20.

Men's experience of their female partners' breast cancer diagnosis, breast surgery and oncological treatment.

Catania AM, Sammut Scerri C, Catania GJ.

J Clin Nurs. 2019 Jan 22. doi: 10.1111/jocn.14800. [Epub ahead of print]

PMID:
30667119

Supplemental Content

Loading ...
Support Center